Keyphrases
Blood-brain Barrier
100%
Inflammatory Cells
100%
Polypeptide
100%
Bone Marrow-derived Monocytes
87%
Catalase
87%
Nanoparticles
62%
Neuroprotection
50%
Patients with Parkinson's Disease
37%
Neuroinflammation
37%
Inflammation
37%
Technology-based
25%
Active Delivery
25%
Parkinson's Disease
25%
Cell Delivery
25%
Cell-mediated
25%
Catalase Activity
12%
Opposite Charge
12%
Palliative Therapy
12%
Parkinson's Disease Treatment
12%
Margination
12%
Carrier Cells
12%
Synthetic Polyelectrolytes
12%
Loading Efficiency
12%
Brain Penetration
12%
Sustained Release
12%
Biodistribution
12%
Neurotransmitters
12%
Endocytosis
12%
Targeted Cells
12%
Exocytosis
12%
Enzymatic Activity
12%
Mouse Bone Marrow
12%
Public Health
12%
Therapeutic Efficacy
12%
Replacement Strategy
12%
Host Cell
12%
Neuroprotection Effect
12%
Health Relevance
12%
Bloodstream
12%
Drug Loading
12%
Polymer Nanoparticles
12%
Block Copolymer
12%
Inflammatory Response
12%
In Vivo Model
12%
Pharmacology, Toxicology and Pharmaceutical Science
Catalase
100%
Polypeptide
100%
Blood-Brain Barrier
100%
Nanoparticle
75%
Parkinson's Disease
75%
Neuroprotection
62%
Inflammation
50%
Nervous System Inflammation
37%
Combination Therapy
25%
Anti-Inflammatory Drug
25%
Copolymer
12%
Neurotransmitter
12%
Extravasation
12%
Biodistribution
12%
Sustained Release
12%
Polyelectrolyte
12%